Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model

Leukemia

Volumn 25, Issue 5, 2011, Pages 888-891

  Tamai, H ^a   Miyake, K ^a   Takatori, M ^a   Miyake, N ^a   Yamaguchi, H ^a   Dan, K ^a   Shimada, T ^a   Inokuchi, K ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; K RAS PROTEIN; MIXED LINEAGE LEUKEMIA AF4 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; B CELL LYMPHOMA; CELL INFILTRATION; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTER; FUSION GENE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HOX GENE; IMMUNOHISTOCHEMISTRY; LETTER; LEUKEMO LYMPHOMOGENICITY; LEUKEMOGENESIS; LEUKOCYTE; LIVER; LUNG; LUNG TUMOR; LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; SPLEEN; SPLENOMEGALY; TRANSGENIC MOUSE; TUMOR CELL;

EID: 79955855891     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.15     Document Type: Letter

References (12)

1. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909-1915. (Pubitemid 34615770)
2. Chen W, Li Q, Hudson WA, Kumar A, Kirchhof N, Kersey JH. A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood 2006; 108: 669-677. (Pubitemid 44061369)
3. Metzler M, Forster A, Pannell R, Arends MJ, Daser A, Lobato MN et al. A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology. Oncogene 2006; 25: 3093-3103. (Pubitemid 43881551)
4. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J et al. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J 1999; 18: 3564-3574. (Pubitemid 29308837)
5. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008; 14: 355-368.
6. Liang DC, Shih LY, Fu JF, Li HY, Wang HI, Hung IJ et al. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements. Cancer 2006; 106: 950-956.
7. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111-1116. (Pubitemid 32391044)
8. Ng MH, Ng RK, Kong CT, Jin DY, Chan LC. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins. Exp Hematol 2010; 38: 481-488.
9. Ono R, Kumagai H, Nakajima H, Hishiya A, Taki T, Horikawa K et al. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia 2009; 23: 2197-2209.
10. Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009; 113: 2375-2385.
11. Bursen A, Schwabe K, Ruster B, Henschler R, Ruthardt M, Dingermann T et al. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Blood 2010; 115: 3570-3579.
12. Stam RW, Schneider P, Hagelstein JA, van der Linden MH, Stumpel DJ, de Menezes RX et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lympho-blastic leukemia in infants. Blood 2010; 115: 2835-2844.